Global Times: How two sessions serve as bridge between people and government, help authorities formulate policies
Retrieved on:
金曜日, 3月 8, 2024
CCTV, China National Radio, Motion, The, Student, NRDL, National Medical Products Administration, Education, News, Party school, Hospital, Pediatrics, Peking University, Sun Jie, Dermatology, Parent, Catalog, World Health Organization, Global Times, Hope, CPPCC, University, SMA, Prevalence, Hematology, Sun, CPC, NPC, Patient, Policy, Real-time, Disease, Diagnosis, Child, National Committee, Economics, WeChat, Research, Insurance, Pharmaceutical industry
Various localities in the country are implementing policies on medication, health insurance and research according to the catalog.
Key Points:
- Various localities in the country are implementing policies on medication, health insurance and research according to the catalog.
- In 2021, China also for the first time included a rare disease treatment in its National Reimbursement Drug List.
- These moves together benefited thousands of Chinese suffering from rare diseases, including spinal muscular atrophy (SMA) patient Zhang Jianuo and his parents.
- Motions and proposals during the two sessions are crucial pathways for addressing issues impacting people's livelihood, and they're becoming increasingly effective.